SevenGenes Overview
- Year Founded
-
2015
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
SevenGenes General Information
Description
Operator of a biopharmaceutical company intended to offer oral delivery treatment solutions. The company specializes in the research and development of drugs to reduce toxicity and increase the bioavailability of hydrophobic drug molecules, enabling patients to avail innovative therapeutics drugs that are safe and efficacious in treating treat pancreatic cancer and other serious human diseases.
Contact Information
Website
www.sevengenes.comCorporate Office
- 1927 Mesa Avenue
- Bartlesville, OK 74006
- United States
Corporate Office
- 1927 Mesa Avenue
- Bartlesville, OK 74006
- United States
SevenGenes Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | Completed | Out of Business | ||||
| 3. Angel (individual) | 30-Nov-2017 | Cancelled | Startup | |||
| 2. Accelerator/Incubator | 13-Jun-2017 | $50K | Completed | Startup | ||
| 1. Early Stage VC | 09-Dec-2016 | $50K | $50K | Completed | Startup |
SevenGenes FAQs
-
When was SevenGenes founded?
SevenGenes was founded in 2015.
-
Where is SevenGenes headquartered?
SevenGenes is headquartered in Bartlesville, OK.
-
What industry is SevenGenes in?
SevenGenes’s primary industry is Drug Discovery.
-
Is SevenGenes a private or public company?
SevenGenes is a Private company.
-
What is SevenGenes’s current revenue?
The current revenue for SevenGenes is .
-
How much funding has SevenGenes raised over time?
SevenGenes has raised $50K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process